Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Briggs KJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cottrell KM; Tango Therapeutics, Boston, Massachusetts 02215, United States., Briggs KJ; Tango Therapeutics, Boston, Massachusetts 02215, United States., Whittington DA; Tango Therapeutics, Boston, Massachusetts 02215, United States., Jahic H; Tango Therapeutics, Boston, Massachusetts 02215, United States., Ali JA; Tango Therapeutics, Boston, Massachusetts 02215, United States., Davis CB; Tango Therapeutics, Boston, Massachusetts 02215, United States., Gong S; Tango Therapeutics, Boston, Massachusetts 02215, United States., Gotur D; Tango Therapeutics, Boston, Massachusetts 02215, United States., Gu L; Tango Therapeutics, Boston, Massachusetts 02215, United States., McCarren P; Tango Therapeutics, Boston, Massachusetts 02215, United States., Tonini MR; Tango Therapeutics, Boston, Massachusetts 02215, United States., Tsai A; Tango Therapeutics, Boston, Massachusetts 02215, United States., Wilker EW; Tango Therapeutics, Boston, Massachusetts 02215, United States., Yuan H; Tango Therapeutics, Boston, Massachusetts 02215, United States., Zhang M; Tango Therapeutics, Boston, Massachusetts 02215, United States., Zhang W; Tango Therapeutics, Boston, Massachusetts 02215, United States., Huang A; Tango Therapeutics, Boston, Massachusetts 02215, United States., Maxwell JP; Tango Therapeutics, Boston, Massachusetts 02215, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Apr 25; Vol. 67 (8), pp. 6064-6080. Date of Electronic Publication: 2024 Apr 10.
Autor:
Koduri V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Duplaquet L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lampson BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Wang AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Sabet AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ishoey M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Paulk J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Teng M; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Harris IS; Ludwig Cancer Center, Boston, MA 02115, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Endress JE; Ludwig Cancer Center, Boston, MA 02115, USA.; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Liu X; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Linde Program in Chemical Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Dasilva E; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Linde Program in Chemical Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Briggs KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Ott CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Bradner J; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Medin JA; Departments of Pediatrics and Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Buhrlage SJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Linde Program in Chemical Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. moser@partners.org william_kaelin@dfci.harvard.edu.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. moser@partners.org william_kaelin@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
Publikováno v:
Science advances [Sci Adv] 2021 Feb 05; Vol. 7 (6). Date of Electronic Publication: 2021 Feb 05 (Print Publication: 2021).
Autor:
Koduri V; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215., McBrayer SK; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215., Liberzon E; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215., Wang AC; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215., Briggs KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215., Cho H; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02215; william_kaelin@dfci.harvard.edu.; Howard Hughes Medical Institute, Chevy Chase, MD 02185.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Feb 12; Vol. 116 (7), pp. 2539-2544. Date of Electronic Publication: 2019 Jan 25.
Autor:
Li AG; Department of Genetics, Harvard Medical School, Boston, MA 02115; andrew_li@dfci.harvard.edu david_livingston@dfci.harvard.edu.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Murphy EC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Culhane AC; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Powell E; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Wang H; Department of Genetics, Harvard Medical School, Boston, MA 02115.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Bronson RT; Department of Pathology, Harvard Medical School, Boston, MA 02115., Von T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215., Giobbie-Hurder A; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215., Gelman RS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA 02115., Briggs KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215., Piwnica-Worms H; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Zhao JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Howard Hughes Medical Institute, Chevy Chase, MD 20815., Livingston DM; Department of Genetics, Harvard Medical School, Boston, MA 02115; andrew_li@dfci.harvard.edu david_livingston@dfci.harvard.edu.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Oct 09; Vol. 115 (41), pp. E9600-E9609. Date of Electronic Publication: 2018 Sep 25.
Autor:
McBrayer SK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Mayers JR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., DiNatale GJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Shi DD; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Khanal J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Chakraborty AA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Sarosiek KA; John B. Little Center for Radiation Sciences, Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Briggs KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Robbins AK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Sewastianik T; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Shareef SJ; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Olenchock BA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Parker SJ; Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA., Tateishi K; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Neurosurgery, Yokohama City University, Yokohama, Kanagawa 2360004, Japan., Spinelli JB; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Islam M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Haigis MC; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA., Looper RE; Department of Chemistry, University of Utah, Salt Lake City, UT 84112, USA., Ligon KL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Pathology, Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Children's Hospital Boston, Boston, MA 02115, USA., Bernstein BE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Carrasco RD; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Cahill DP; Department of Neurosurgery, Translational Neuro-Oncology Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA., Asara JM; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Metallo CM; Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA., Yennawar NH; Huck Institutes of the Life Sciences, Pennsylvania State University, University Park, PA 16802, USA., Vander Heiden MG; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: william_kaelin@dfci.harvard.edu.
Publikováno v:
Cell [Cell] 2018 Sep 20; Vol. 175 (1), pp. 101-116.e25. Date of Electronic Publication: 2018 Sep 13.
Autor:
Briggs KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02215, USA., Koivunen P; Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, Oulu Center for Cell-Matrix Research, University of Oulu, FIN-90014 Oulu, Finland., Cao S; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Backus KM; The Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Olenchock BA; Division of Cardiovascular Medicine, Department of Medicine, The Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Patel H; Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Zhang Q; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Gerfen GJ; Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA., Witkiewicz AK; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA., Cravatt BF; The Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Clardy J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Kaelin WG Jr; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA 02215, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: william_kaelin@dfci.harvard.edu.
Publikováno v:
Cell [Cell] 2016 Jun 30; Vol. 166 (1), pp. 126-39.
Autor:
Ohm JE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA., Mali P, Van Neste L, Berman DM, Liang L, Pandiyan K, Briggs KJ, Zhang W, Argani P, Simons B, Yu W, Matsui W, Van Criekinge W, Rassool FV, Zambidis E, Schuebel KE, Cope L, Yen J, Mohammad HP, Cheng L, Baylin SB
Publikováno v:
Cancer research [Cancer Res] 2010 Oct 01; Vol. 70 (19), pp. 7662-73. Date of Electronic Publication: 2010 Sep 14.
Autor:
Buonamici S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Williams J, Morrissey M, Wang A, Guo R, Vattay A, Hsiao K, Yuan J, Green J, Ospina B, Yu Q, Ostrom L, Fordjour P, Anderson DL, Monahan JE, Kelleher JF, Peukert S, Pan S, Wu X, Maira SM, García-Echeverría C, Briggs KJ, Watkins DN, Yao YM, Lengauer C, Warmuth M, Sellers WR, Dorsch M
Publikováno v:
Science translational medicine [Sci Transl Med] 2010 Sep 29; Vol. 2 (51), pp. 51ra70.